 MENLO PARK, Calif., May 06, 2021 GLOBE NEWSWIRE -- Corcept Therapeutics Incorporated NASDAQ: CORT, a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the stress hormone cortisol, today reported its results for the quarter ended March 31, 2021. 